glp-1 or semaglutide Another Weight-Loss Trial Win for Weekly Drug Semaglutide vs. Other GLP-1 Receptor
Description
it should be used at the lowest effective dose for the shortest possible duration
Discuss with your provider which formulation aligns with your lifestyle
TIR;4.7 22.2 vs
However, treatment with semaglutide was associated with occurrence of NAION, despite the fact that no definitive conclusions regarding this association could be drawn. Clinical Implications Semaglutide does not appear to increase or reduce risk for DR or general ocular adverse events
